Ubs Group Ag P Lx Pharma Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.12 - $0.3 $3,901 - $9,753
-32,510 Reduced 38.83%
51,213 $6,000
Q4 2022

Feb 08, 2023
BUY
$0.15 - $0.63 $4,162 - $17,483
27,752 Added 49.58%
83,723 $13,000
Q3 2022

Nov 10, 2022
BUY
$0.52 - $3.08 $2,516 - $14,904
4,839 Added 9.46%
55,971 $36,000
Q1 2022

May 16, 2022
SELL
$3.54 - $8.3 $25,810 - $60,515
-7,291 Reduced 12.48%
51,132 $207,000
Q4 2021

Feb 14, 2022
BUY
$7.69 - $19.66 $141,688 - $362,235
18,425 Added 46.06%
58,423 $468,000
Q3 2021

Nov 15, 2021
BUY
$12.22 - $21.28 $280,888 - $489,142
22,986 Added 135.12%
39,998 $772,000
Q2 2021

Aug 13, 2021
BUY
$9.0 - $15.94 $28,449 - $50,386
3,161 Added 22.82%
17,012 $235,000
Q1 2021

May 12, 2021
BUY
$5.24 - $10.14 $60,422 - $116,924
11,531 Added 497.03%
13,851 $125,000
Q4 2020

Feb 11, 2021
SELL
$3.01 - $6.7 $4,433 - $9,869
-1,473 Reduced 38.83%
2,320 $13,000
Q3 2020

Nov 12, 2020
BUY
$2.83 - $4.21 $7,754 - $11,535
2,740 Added 260.21%
3,793 $12,000
Q2 2020

Jul 31, 2020
SELL
$2.32 - $4.02 $1,811 - $3,139
-781 Reduced 42.58%
1,053 $3,000
Q1 2020

May 01, 2020
BUY
$1.98 - $5.87 $1,546 - $4,584
781 Added 74.17%
1,834 $4,000
Q3 2019

Nov 14, 2019
SELL
$4.89 - $7.18 $12,180 - $17,885
-2,491 Reduced 70.29%
1,053 $5,000
Q2 2019

Aug 14, 2019
BUY
$4.93 - $7.2 $3,091 - $4,514
627 Added 21.49%
3,544 $26,000
Q1 2019

May 14, 2019
SELL
$2.05 - $6.0 $19,669 - $57,570
-9,595 Reduced 76.69%
2,917 $16,000
Q4 2018

Feb 14, 2019
SELL
$1.22 - $4.38 $938 - $3,368
-769 Reduced 5.79%
12,512 $19,000
Q3 2018

Nov 14, 2018
BUY
$3.18 - $5.15 $4,582 - $7,421
1,441 Added 12.17%
13,281 $54,000
Q2 2018

Aug 14, 2018
SELL
$3.3 - $4.5 $7,118 - $9,706
-2,157 Reduced 15.41%
11,840 $46,000
Q1 2018

May 15, 2018
BUY
$3.2 - $7.43 $3,475 - $8,068
1,086 Added 8.41%
13,997 $47,000
Q4 2017

Feb 14, 2018
BUY
$6.3 - $9.1 $6,747 - $9,746
1,071 Added 9.05%
12,911 $89,000
Q3 2017

Nov 14, 2017
BUY
$6.08 - $7.0 $71,664 - $82,509
11,787 Added 22239.62%
11,840 $76,000
Q2 2017

Aug 14, 2017
BUY
N/A
53
53 $0

Others Institutions Holding PLXP

# of Institutions
6
Shares Held
62.7K
Call Options Held
0
Put Options Held
0
View Full List

About PLx Pharma Inc.

PLXP Quotes by TradingView
  • Ticker PLXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,137,700
  • Description
  • PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...
More about PLXP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email